In a 16-week open-label randomized controlled study , 1511 T2DM patients with inadequate responses to two or more oral antidiabetic drugs ( OADs ) for > 3 months ( HbA1c > 7.5 % ) were randomized ( 1:1 ) to either an education group ( structured diabetes education plus insulin therapy ) or a control group ( usual care plus insulin therapy ) .